vs
COMERICA INC（CMA）与FMC CORP（FMC）财务数据对比。点击上方公司名可切换其他公司
FMC CORP的季度营收约是COMERICA INC的1.3倍（$1.1B vs $838.0M），COMERICA INC净利率更高（21.0% vs -158.8%，领先179.9%），COMERICA INC同比增速更快（3.3% vs -11.5%），过去两年COMERICA INC的营收复合增速更高（108.9% vs 8.6%）
Comerica公司是总部位于美国得克萨斯州达拉斯的金融服务企业，为美国大型金融控股公司之一。旗下Comerica银行为区域性商业银行，在得克萨斯、密歇根、加利福尼亚、佛罗里达、亚利桑那五州共设413家网点，在美国多座城市设有办公场所。
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业，1883年创立之初以生产杀虫剂为主，后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车，目前在全球拥有7000名员工，业务布局广泛。
CMA vs FMC — 直观对比
营收规模更大
FMC
是对方的1.3倍
$838.0M
营收增速更快
CMA
高出14.8%
-11.5%
净利率更高
CMA
高出179.9%
-158.8%
两年增速更快
CMA
近两年复合增速
8.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $838.0M | $1.1B |
| 净利润 | $176.0M | $-1.7B |
| 毛利率 | — | 39.8% |
| 营业利润率 | — | -130.8% |
| 净利率 | 21.0% | -158.8% |
| 营收同比 | 3.3% | -11.5% |
| 净利润同比 | -4.3% | -10457.1% |
| 每股收益（稀释后） | $1.35 | $-13.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMAFMC
| Q4 25 | — | $1.1B | ||
| Q3 25 | $838.0M | $542.2M | ||
| Q2 25 | $849.0M | $1.1B | ||
| Q1 25 | $829.0M | $791.4M | ||
| Q4 24 | $825.0M | $1.2B | ||
| Q3 24 | $811.0M | $1.1B | ||
| Q2 24 | $824.0M | $1.0B | ||
| Q1 24 | $784.0M | $918.0M |
净利润CMAFMC
| Q4 25 | — | $-1.7B | ||
| Q3 25 | $176.0M | $-569.3M | ||
| Q2 25 | $199.0M | $66.7M | ||
| Q1 25 | $172.0M | $-15.5M | ||
| Q4 24 | $170.0M | $-16.3M | ||
| Q3 24 | $184.0M | $65.0M | ||
| Q2 24 | $206.0M | $295.1M | ||
| Q1 24 | $138.0M | $-2.7M |
毛利率CMAFMC
| Q4 25 | — | 39.8% | ||
| Q3 25 | — | 23.8% | ||
| Q2 25 | — | 38.7% | ||
| Q1 25 | — | 40.0% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 36.3% | ||
| Q2 24 | — | 38.3% | ||
| Q1 24 | — | 37.0% |
营业利润率CMAFMC
| Q4 25 | — | -130.8% | ||
| Q3 25 | — | -73.1% | ||
| Q2 25 | — | 12.0% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 6.0% | ||
| Q1 24 | — | 8.1% |
净利率CMAFMC
| Q4 25 | — | -158.8% | ||
| Q3 25 | 21.0% | -105.0% | ||
| Q2 25 | 23.4% | 6.3% | ||
| Q1 25 | 20.7% | -2.0% | ||
| Q4 24 | 20.6% | -1.3% | ||
| Q3 24 | 22.7% | 6.1% | ||
| Q2 24 | 25.0% | 28.4% | ||
| Q1 24 | 17.6% | -0.3% |
每股收益（稀释后）CMAFMC
| Q4 25 | — | $-13.77 | ||
| Q3 25 | $1.35 | $-4.52 | ||
| Q2 25 | $1.42 | $0.53 | ||
| Q1 25 | $1.25 | $-0.12 | ||
| Q4 24 | $1.22 | $-0.13 | ||
| Q3 24 | $1.33 | $0.52 | ||
| Q2 24 | $1.49 | $2.35 | ||
| Q1 24 | $0.98 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $584.5M |
| 总债务越低越好 | $5.4B | $3.4B |
| 股东权益账面价值 | $7.4B | $2.1B |
| 总资产 | $77.4B | $9.7B |
| 负债/权益比越低杠杆越低 | 0.73× | 1.62× |
8季度趋势，按日历期对齐
现金及短期投资CMAFMC
| Q4 25 | — | $584.5M | ||
| Q3 25 | — | $497.7M | ||
| Q2 25 | — | $438.2M | ||
| Q1 25 | — | $315.3M | ||
| Q4 24 | — | $357.3M | ||
| Q3 24 | — | $416.7M | ||
| Q2 24 | — | $471.5M | ||
| Q1 24 | — | $417.8M |
总债务CMAFMC
| Q4 25 | — | $3.4B | ||
| Q3 25 | $5.4B | $3.4B | ||
| Q2 25 | $5.8B | $3.4B | ||
| Q1 25 | $5.7B | $3.1B | ||
| Q4 24 | $6.7B | $3.1B | ||
| Q3 24 | $6.8B | $3.1B | ||
| Q2 24 | $7.1B | $3.1B | ||
| Q1 24 | $7.1B | $3.1B |
股东权益CMAFMC
| Q4 25 | — | $2.1B | ||
| Q3 25 | $7.4B | $3.8B | ||
| Q2 25 | $6.9B | $4.4B | ||
| Q1 25 | $7.1B | $4.4B | ||
| Q4 24 | $6.5B | $4.5B | ||
| Q3 24 | $7.4B | $4.6B | ||
| Q2 24 | $6.2B | $4.6B | ||
| Q1 24 | $6.0B | $4.3B |
总资产CMAFMC
| Q4 25 | — | $9.7B | ||
| Q3 25 | $77.4B | $12.1B | ||
| Q2 25 | $78.0B | $12.3B | ||
| Q1 25 | $77.6B | $11.8B | ||
| Q4 24 | $79.3B | $11.7B | ||
| Q3 24 | $79.7B | $12.2B | ||
| Q2 24 | $79.6B | $12.1B | ||
| Q1 24 | $79.4B | $12.0B |
负债/权益比CMAFMC
| Q4 25 | — | 1.62× | ||
| Q3 25 | 0.73× | 0.89× | ||
| Q2 25 | 0.84× | 0.76× | ||
| Q1 25 | 0.81× | 0.71× | ||
| Q4 24 | 1.02× | 0.69× | ||
| Q3 24 | 0.92× | 0.68× | ||
| Q2 24 | 1.15× | 0.68× | ||
| Q1 24 | 1.18× | 0.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-270.0M | $657.1M |
| 自由现金流经营现金流 - 资本支出 | — | $631.1M |
| 自由现金流率自由现金流/营收 | — | 58.3% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | -1.53× | — |
| 过去12个月自由现金流最近4个季度 | — | $-102.5M |
8季度趋势，按日历期对齐
经营现金流CMAFMC
| Q4 25 | — | $657.1M | ||
| Q3 25 | $-270.0M | $-184.2M | ||
| Q2 25 | $476.0M | $65.9M | ||
| Q1 25 | $273.0M | $-545.0M | ||
| Q4 24 | $601.0M | $427.9M | ||
| Q3 24 | $1.0B | $159.5M | ||
| Q2 24 | $111.0M | $292.2M | ||
| Q1 24 | $-205.0M | $-142.9M |
自由现金流CMAFMC
| Q4 25 | — | $631.1M | ||
| Q3 25 | — | $-207.9M | ||
| Q2 25 | — | $50.9M | ||
| Q1 25 | — | $-576.6M | ||
| Q4 24 | — | $406.3M | ||
| Q3 24 | — | $143.8M | ||
| Q2 24 | — | $282.3M | ||
| Q1 24 | — | $-163.6M |
自由现金流率CMAFMC
| Q4 25 | — | 58.3% | ||
| Q3 25 | — | -38.3% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | -72.9% | ||
| Q4 24 | — | 33.2% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | — | 27.2% | ||
| Q1 24 | — | -17.8% |
资本支出强度CMAFMC
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 2.3% |
现金转化率CMAFMC
| Q4 25 | — | — | ||
| Q3 25 | -1.53× | — | ||
| Q2 25 | 2.39× | 0.99× | ||
| Q1 25 | 1.59× | — | ||
| Q4 24 | 3.54× | — | ||
| Q3 24 | 5.70× | 2.45× | ||
| Q2 24 | 0.54× | 0.99× | ||
| Q1 24 | -1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMA
暂无分部数据
FMC
| Insecticides | $440.3M | 41% |
| Herbicides | $378.8M | 35% |
| Fungicides | $140.4M | 13% |
| Plant Health | $65.6M | 6% |
| Other | $45.0M | 4% |
